SCHEMBL25000354

SCHEMBL25000354

c1ccc(-c2ccc(-c3ccc(N(c4cccc5ccccc45)c4cccc5c4oc4c(-c6ccccc6)cccc45)cc3)cc2-c2ccccc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA9 Q16790 2/20 0.35
▸ PRKDC P78527 7/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ SLC6A9 P48067 1/20 0.32
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ PIK3CD O00329 3/20 0.32
▸ PIK3CA P42336 3/20 0.32
▸ PIK3CB P42338 3/20 0.32
▸ PIK3CG P48736 3/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ BRD4 O60885 2/20 0.32
▸ BRD2 P25440 2/20 0.32
▸ BRD3 Q15059 2/20 0.32
▸ PDE2A O00408 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25629067 0.94 PRKDC (0.38) PRKDCALOX5PIK3CDPIK3CAPIK3CB
SCHEMBL25629065 0.93 CA12 (0.40) CA12CA1CA2CA9PRKDC
SCHEMBL18998314 0.93 ALOX5 (0.35) CA12CA1CA2CA9PRKDC
SCHEMBL17703152 0.93 ALOX5 (0.35) CA12CA1CA2CA9PRKDC
SCHEMBL25000355 0.92 PRKDC (0.38) PRKDCALOX5PIK3CDPIK3CAPIK3CB
SCHEMBL24999732 0.92 PRKDC (0.38) PRKDCALOX5PIK3CDPIK3CAPIK3CB
SCHEMBL25000657 0.91 CA12 (0.38) CA12CA1CA2CA9PRKDC
SCHEMBL26416351 0.91 PRKDC (0.38) CA12CA1CA2CA9PRKDC
SCHEMBL25629102 0.91 CA12 (0.38) CA12CA1CA2CA9PRKDC
SCHEMBL19103186 0.91 SIGMAR1 (0.34) CA12CA1CA2CA9PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 — — US disclosed
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 — — US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 — — US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 — — US disclosed
EP-4129972-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co.,Ltd. (JP) 2023-02-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM CA12 1391/4885CA1 1719/4885CA2 2579/4885
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device PIEZO1, LEF1, L1CAM CA12 1391/4885CA1 1719/4885CA2 2579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback